Objectives
This project intends to assess, up to one year, the role of autologous mesenchymal stem cells in improvement of kidney function in patients with chronic kidney disease (CKD). Therefore the main and practical objective of this study is to evaluate the effect of intravenous injection of autologous mesenchymal stem cells on kidney function trends.
Design:
In this study, 15 male and female CKD patients who have a GFR between 15-30 ml/mil will be enrolled.
Setting and conduct, participants and intervention:
Patients will be selected from a list of patients attending the nephrology clinic of Dr. Shariati Hospital. After obtaining the consent form, the bone marrow aspiration will be performed by hematologist and then in the specialized lab, the mesenchymal stem cells will be separated and cultured to reach appropriate number (106/kg). The cells will be injected through peripheral vein in hospital setting. Patients will be followed-up (clinically and laboratory) every two months up to one year. The clinical assessment and necessary biochemical tests will be performed in each visit. The trends of kidney function (serum creatinin and GFR) in last year before injection for each patient will be regarded as the control for that patient.
Outcome measures:
Periodic assessments of serum BUN and creatinin, urine protein and creatinin, GFR and clinical evaluation of patients for high blood pressure or probable complications.
General information
Acronym
IRCT registration information
IRCT registration number:IRCT201204248349N1
Registration date:2015-05-10, 1394/02/20
Registration timing:registered_while_recruiting
Last update:
Update count:0
Registration date
2015-05-10, 1394/02/20
Registrant information
Name
Iraj Najafi
Name of organization / entity
Tehran University of Meical Scienses
Country
Iran (Islamic Republic of)
Phone
+98 21 8490 2469
Email address
najafi@tums.ac.ir
Recruitment status
Recruitment complete
Funding source
Presidency of the Islamic Republic of Iran, Vice- Presidency for Science and Technology
Expected recruitment start date
2014-01-30, 1392/11/10
Expected recruitment end date
2016-12-30, 1395/10/10
Actual recruitment start date
empty
Actual recruitment end date
empty
Trial completion date
empty
Scientific title
Evaluation of effects of injected autologous mesenchymal stem cells on kidney function in patients with chronic kidney disease
Public title
Effects of mesenchymal stem cell therapy in patients with chronic kidney disease
Purpose
Treatment
Inclusion/Exclusion criteria
Inclusion Criteria:
1-CKD patient
2- GFR between 15-30 mml/min
3- No serious underlying disease
4- Availability of previous medical records for creatinin and GFR
5- Age between 18-65 years
The necessary information will be given to patients before enrollment and patient will sign the consent form.
Exclusion Criteria:
1- Serious mental disorders (suicide history, major depression)
2- Patients who cannot come for regular visits
3- Less than one year survival
4- Patients who use immunosuppressive drug
5- Pregnancy
6- Congestive Heart Failure (CHF)
7- Malignancy
8- Coagulation disorders
9- Uncontrolled hypertension
10- Positive virology tests
11- Infection or osteomyelitis in bone marrow aspiration site
12- Hb<8 g/dL, platelet <100,000
Age
From 18 years old to 65 years old
Gender
Both
Phase
N/A
Groups that have been masked
No information
Sample size
Target sample size:
15
Randomization (investigator's opinion)
N/A
Randomization description
Blinding (investigator's opinion)
Not blinded
Blinding description
Placebo
Not used
Assignment
Single
Other design features
Secondary Ids
empty
Ethics committees
1
Ethics committee
Name of ethics committee
Sciences Ethics committee of Tehran University Of Medical Sciences
Street address
6th floor, central building of TUMS, Ghods street, Keshavarz Blv, Tehran, Iran
City
Tehran
Postal code
1417653761
Approval date
2012-02-22, 1390/12/03
Ethics committee reference number
90/D/2310/130
Health conditions studied
1
Description of health condition studied
Chronic Kidney Disease (CKD)
ICD-10 code
N18.1, N18
ICD-10 code description
Kidney damage with decreased GFR
Primary outcomes
1
Description
Blood pressure
Timepoint
Before and every two months after intervention up to one year
Method of measurement
Mercury sphygmomanometer
2
Description
Serum creatinin
Timepoint
Baseline and every two months after intervention up to one year
Method of measurement
Autoanalyser
3
Description
Glomerular filtration rate (GFR)
Timepoint
Baseline and every two months after intervention up to one year
Method of measurement
MDRD formula
4
Description
Urine creatinin
Timepoint
Baseline and every two months after intervention up to one year
Method of measurement
24 h urine collection
5
Description
Urine Protein
Timepoint
Baseline and every two months after intervention up to one year
Method of measurement
24 h urine collection
Secondary outcomes
1
Description
Need to dialysis
Timepoint
Baseline and every two months after intervention
Method of measurement
Serum creatinin
2
Description
Stem cell injection complications
Timepoint
Baseline and every two months after intervention
Method of measurement
Biochemical and clinical assessment of patients
Intervention groups
1
Description
Intervention group: single peripheral injection of autologous mesenchymal stem cells (1,000,000/kg).
The mesenchymal stem cells will be separated from bone marrow aspiration sample and then the cells will be cultured and proliferated in specialized lab until they reach enough numbers and then they will be injected through peripheral vein into the circulation. the injection will be performed only one time.
Category
Treatment - Other
Recruitment centers
1
Recruitment center
Name of recruitment center
Dr. Shariati Hospital, Nephrology Research Center
Full name of responsible person
Dr sudabeh alatab
Street address
4th floor, Dr. Shariati Hospital, North Karger Ave, Tehran, Iran
City
Tehran
Sponsors / Funding sources
1
Sponsor
Name of organization / entity
Presidency of the Islamic Republic of Iran, Vice-Presidency for Science and Technology
Full name of responsible person
Mr. Sajadian
Street address
Presidency of the Islamic Republic of Iran, Vice-Presidency for Science and Technology, Number 7, Avesta street, Sheikh Bahaee square, Molasadra Ave.
City
Tehran
Grant name
Grant code / Reference number
Is the source of funding the same sponsor organization/entity?
Yes
Title of funding source
Presidency of the Islamic Republic of Iran, Vice-Presidency for Science and Technology
Proportion provided by this source
100
Public or private sector
empty
Domestic or foreign origin
empty
Category of foreign source of funding
empty
Country of origin
Type of organization providing the funding
empty
Person responsible for general inquiries
Contact
Name of organization / entity
Urology research Center, Sina Hospital
Full name of responsible person
Dr. Sudabeh Alatab
Position
Medical doctor
Other areas of specialty/work
Street address
Urology Research Center, Sina Hospital, Hassan-Abad Sq. Emam Khomeini St. Tehran, Iran
City
Tehran
Postal code
1136746911
Phone
+98 21 6634 8560
Fax
Email
sudabehalatab@yahoo.com
Web page address
Person responsible for scientific inquiries
Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Dr. Iraj Najafi
Position
Nephrologist
Other areas of specialty/work
Street address
4th Floor, Dr. Shariati hospital, North Kargar Ave. Tehran, Iran
City
Tehran
Postal code
1411713135
Phone
+98 21 8490 2469
Fax
Email
najafi@tums.ac.ir
Web page address
Person responsible for updating data
Contact
Name of organization / entity
Tehran University of Medical Sciences
Full name of responsible person
Dr. Sudabeh Alatab
Position
MD
Other areas of specialty/work
Street address
Urology Research Center, Sina Hospital, Hassan-Abad Sq. Emam Khomeini St. Tehran, Iran
City
Tehran
Postal code
1136746911
Phone
+98 21 6634 8560
Fax
Email
sudabehalatab@yahoo.com
Web page address
Sharing plan
Deidentified Individual Participant Data Set (IPD)